試す - 無料

Saving Lives with BSL-4 Labs

Bio Spectrum

|

February 2026

Starting a new era of India's health security, a biosafety level 4 (BSL-4) lab is being built at the cost of Rs 362 crore at Gujarat Biotechnology Research Centre in Gandhinagar. Although this will be India's second high-level lab after the National Institute of Virology in Pune (established in 2012), this is the first lab being built by a state government, with an area of 11,000 square metres. Back in 2024, the Defence Research and Development Organisation (DRDO) took a significant step in enhancing India's chemical-biological defence capabilities with the inauguration of a BSL-4 laboratory at the Defence Research and Development Establishment (DRDE) in Gwalior.

- Dr Manbeena Chawla

Saving Lives with BSL-4 Labs

India has been lagging behind for many years due to the cutting-edge research being done in the world, but the establishment of such BSL-4 bio-containment facilities in the country can provide new opportunities to the youth working in the biotechnology sector and help India emerge as a global leader in years to come.

According to reports, with 3,000 square metres of lab space, the Wuhan Institute of Virology in China is one the largest BSL-4 lab in the world, later overtaken by the National Bio and Agro-Defense Facility at Kansas State University in the US which boasts over 50,000 square metres of lab space including BSL-3 and BSL-4 facilities.

The global distribution of BSL-4 laboratories has evolved significantly over the past few decades, reflecting the growing recognition of the need for high-containment facilities in various regions. While historically concentrated in North America and Europe, there has been a notable increase in BSL-4 labs across Asia, Africa, and Australia in recent years.

Bio Spectrum からのその他のストーリー

Bio Spectrum

Bio Spectrum

India & Australia develop precision nano-injection platform for breast cancer drug delivery

Researchers from the Indian Institute of Technology Madras (IIT-M), Monash University and Deakin University, Australia, have developed a cutting-edge nano-injection drug delivery platform that has the potential to make breast cancer treatment safer and more effective.

time to read

1 min

February 2026

Bio Spectrum

Agilent opens India Refurbishment Centre in Manesar

Agilent Technologies Inc., a global leader in life sciences, diagnostics, and applied chemical markets, has announced the inauguration of its India Refurbishment Centre at its LEED Platinum-certified facility in Manesar, Haryana.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Yashoda Medicity appoints Dr Rajinder Kumar as Unit Head, Department of Neurosurgery

Yashoda Medicity, one of the leading hospitals in the Delhi NCR, has appointed Prof. Dr Rajinder Kumar as Principal Director & Unit Head, Neurosurgery at the Yashoda Institute of Neurosciences.

time to read

1 min

February 2026

Bio Spectrum

Park Medi World buys KP Institute of Medical Sciences for Rs 245 Cr

Park Medi World Limited, North India's second largest chain of hospitals, has agreed to acquire KP Institute of Medical Sciences (KPIMS), in an all-cash transaction amounting to Rs 245 crore.

time to read

1 min

February 2026

Bio Spectrum

146 Biosimilars in 25 Years: India at Global Scale

Biosimilars are an important part of modern therapeutics and a central component of India's shift beyond a generics-led pharmaceutical model.

time to read

8 mins

February 2026

Bio Spectrum

Decode Age raises Rs 14.48 Cr to advance longevity science and gut microbiome research

Bengaluru-based Decode Age, a longevity science organisation focused on ageing biology, biomarker research and gut microbiome science, has raised Rs 14.48 crore in its Pre Series A funding round led by Dr Krishna Prasad Chigurupati, Chairman and Managing Director, Granules India Limited.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Havih Envirosciences announces partnership with Andhra Pradesh

Havih Envirosciences, a subsidiary of Maxwell Biosciences, has announced a strategic partnership with the Government of Andhra Pradesh to establish advanced pharmaceutical research and production capabilities in the state.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Biofabri and Bharat Biotech ink technology transfer agreement to advance global access to MTBVAC

Biofabri, a global human vaccine development company that is part of Spain-based Zendal group, and Bharat Biotech International Limited (BBIL) in Hyderabad, a global leader in vaccine innovation and manufacturing, have announced the signing of a Technology Transfer Agreement.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

IIT-D and AIIMS develop swallowable microdevice for microbiome study

Researchers at the Indian Institute of Technology (IIT) Delhi, and All India Institute of Medical Sciences (AIIMS) have developed an ingestible device that can sample bacteria directly from the small intestine, opening a new window into the human gut microbiome.

time to read

1 min

February 2026

Bio Spectrum

Bio Spectrum

Care ADHD expands global operations with first GCC in India

Care ADHD, one of the United Kingdom's fastest growing digital mental health companies and a key partner to the NHS, has announced the opening of its first Global Capability Centre (GCC) in India - Bengaluru.

time to read

1 min

February 2026

Listen

Translate

Share

-
+

Change font size